1. Home
  2. HSDT vs BACK Comparison

HSDT vs BACK Comparison

Compare HSDT & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • BACK
  • Stock Information
  • Founded
  • HSDT 2014
  • BACK 2000
  • Country
  • HSDT United States
  • BACK United States
  • Employees
  • HSDT N/A
  • BACK N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BACK Medical Specialities
  • Sector
  • HSDT Health Care
  • BACK Health Care
  • Exchange
  • HSDT Nasdaq
  • BACK Nasdaq
  • Market Cap
  • HSDT 1.8M
  • BACK 2.1M
  • IPO Year
  • HSDT N/A
  • BACK 2019
  • Fundamental
  • Price
  • HSDT $0.49
  • BACK $1.02
  • Analyst Decision
  • HSDT Buy
  • BACK
  • Analyst Count
  • HSDT 2
  • BACK 0
  • Target Price
  • HSDT $24.00
  • BACK N/A
  • AVG Volume (30 Days)
  • HSDT 116.7K
  • BACK 36.3K
  • Earning Date
  • HSDT 11-12-2024
  • BACK 11-26-2024
  • Dividend Yield
  • HSDT N/A
  • BACK N/A
  • EPS Growth
  • HSDT N/A
  • BACK N/A
  • EPS
  • HSDT N/A
  • BACK N/A
  • Revenue
  • HSDT $502,000.00
  • BACK N/A
  • Revenue This Year
  • HSDT $16.41
  • BACK N/A
  • Revenue Next Year
  • HSDT $31.97
  • BACK N/A
  • P/E Ratio
  • HSDT N/A
  • BACK N/A
  • Revenue Growth
  • HSDT N/A
  • BACK N/A
  • 52 Week Low
  • HSDT $0.37
  • BACK $1.00
  • 52 Week High
  • HSDT $9.50
  • BACK $7.75
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 48.71
  • BACK 35.53
  • Support Level
  • HSDT $0.44
  • BACK $1.00
  • Resistance Level
  • HSDT $0.58
  • BACK $1.35
  • Average True Range (ATR)
  • HSDT 0.05
  • BACK 0.10
  • MACD
  • HSDT 0.01
  • BACK -0.02
  • Stochastic Oscillator
  • HSDT 42.65
  • BACK 5.68

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About BACK IMAC Holdings Inc.

IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.

Share on Social Networks: